Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, is the abnormal growth of cells (neoplasia) or lesions on your outer cervix lining (intraepithelial). CIN can be ...

Here are 5 important questions to ask if you’ve been told you have cervical dysplasia: ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

CIN: Cervical intraepithelial neoplasia; HPV: Human papillomavirus. Genome organization of the papillomavirus. HPV16 from the α9 group of papillomaviruses. HPV: Human papillomavirus; LCR ...

Another term for cervical dysplasia is cervical intraepithelial neoplasia, or CIN. The exact cause of cervical dysplasia is not known, however it has been linked to the human papillomavirus (HPV).

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results from ...

“Our findings demonstrate that the therapeutic vaccine Vvax001 is safe, well-tolerated, and effective in eradicating HPV16-associated CIN3 lesions and clearing the underlying persistent HPV16 ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions ...

Cervical cancer screening traditionally relies on the Pap smear and HPV-DNA tests. While effective, these methods are fraught with challenges, including variability in human interpretation, false ...

Human papillomavirus (HPV) vaccines are in wide use around the world owing to the widespread implementation of immunization programs for young girls before they become sexually active. The phase ...